Ascribe seeks AIM listing
Medicines management software specialist, Ascribe is poised to seek a listing on the Alternative Investment Market (AIM) and raise £5.5m to develop the company. Ascribe, which was established in 1989, expects to have a stock market capitalisation of about £20m. Managing director, Stephen Critchlow, a former hospital pharmacist, confirmed to E-Health Insider that the funds raised by […]
News
Multilex Announces Enhanced Sensitivity Checking
First DataBank Europe , the provider of point-of-care databases has launched Enhanced Sensitivity Checking as a new feature of its Multilex Drug Data File Multilex DDF). The new feature offers a more sophisticated way to highlight potential drug – patient sensitivity safety issues to clinicians, a key requirement in reducing medication errors. Previously, within electronic […]
News
IT Needed to Cut Drug Deaths
A new report by the Audit Commission has highlighted the need to invest in IT systems to cut the increasing number of patients who die after being given the wrong drugs in hospital. Approximately 1,200 people died last year in England and Wales as a result of the medication errors often caused by ineffective information […]
News